Rheumatology Academy

Where education meets excellence.
The latest rheumatology CME
& clinical updates you need.

Where education meets excellence.
The latest rheumatology CME & clinical updates you need.

Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
Clinician's Roundtable
Evaluating the Safety of Ixekizumab in Psoriasis and Arthritis Patients
- Atul A. Deodhar, MD, MRCP
Osteoporosis in Postmenopausal Women: Sequencing Strategies and Challenges
Osteoporosis in Postmenopausal Women: Sequencing Strategies and Challenges
OB/GYN and Women's Health
Osteoporosis in Postmenopausal Women: Sequencing Strategies and Challenges
- Felicia Cosman, MD
Optimizing Anabolic and Antiresorptive Treatment Transitions for Osteoporosis
Optimizing Anabolic and Antiresorptive Treatment Transitions for Osteoporosis
OB/GYN and Women's Health
Optimizing Anabolic and Antiresorptive Treatment Transitions for Osteoporosis
- Felicia Cosman, MD
Preventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
Preventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
OB/GYN and Women's Health
Preventing Osteoporosis with Hormone Therapy: How to Select Appropriate Patients
- Risa Kagan, MD, FACOG, CCD, NCMP
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
Living Rheum
Enhancing Lupus Nephritis Outcomes: The Potential Impact of Lower Glucocorticoid Doses
Navigating Pregnancy with Lupus: Understanding Risks and Improving Outcomes
Navigating Pregnancy with Lupus: Understanding Risks and Improving Outcomes
Living Rheum
Navigating Pregnancy with Lupus: Understanding Risks and Improving Outcomes
Treating Skin Manifestations of Connective Tissue Diseases
Treating Skin Manifestations of Connective Tissue Diseases
Clinician's Roundtable
Treating Skin Manifestations of Connective Tissue Diseases
Achieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
Achieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
AudioAbstracts
Achieving Optimal Outcomes in Lupus Nephritis: Key Updates from the 2024 ACR Guidelines
- Robin Dore, MD